Appili gets US FDA approval for oral antibiotic solution

Appili Therapeutics

25/09/2023 13:00

Sept 25 (Reuters) - The U.S. Food and Drug
Administration (FDA) on Monday approved the use of Appili
Therapeutics'  APLI.TO  liquid oral form of antibiotic drug
metronidazole, giving an easier option to patients who often
have difficulty taking injections or pills. 
    An injectable form of the drug, which is commonly used in
the treatment of bacterial and parasitic infections, has been in
shortage since early last year due to high demand and regulatory
delays. 
        
  

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Shweta
Agarwal)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))